摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,4-anhydro-2-deoxy-2-fluoro-3,5-di-O-benzoyl-4-thio-D-arabinitol | 878384-17-9

中文名称
——
中文别名
——
英文名称
1,4-anhydro-2-deoxy-2-fluoro-3,5-di-O-benzoyl-4-thio-D-arabinitol
英文别名
[(2R,3S,4S)-3-benzoyloxy-4-fluorothiolan-2-yl]methyl benzoate
1,4-anhydro-2-deoxy-2-fluoro-3,5-di-O-benzoyl-4-thio-D-arabinitol化学式
CAS
878384-17-9
化学式
C19H17FO4S
mdl
——
分子量
360.406
InChiKey
UQSXZFXATJISGE-ZACQAIPSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    25
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    77.9
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,4-anhydro-2-deoxy-2-fluoro-3,5-di-O-benzoyl-4-thio-D-arabinitol臭氧 作用下, 以 二氯甲烷 为溶剂, 反应 0.5h, 以99%的产率得到1,4-anhydro-2-deoxy-2-fluoro-3,5-di-O-benzoyl-4-sulfinyl-D-arabinitol
    参考文献:
    名称:
    Synthesis and Conformational Analysis of 2‘-Fluoro-5-methyl-4‘-thioarabinouridine (4‘S-FMAU)
    摘要:
    An improved synthesis of 2'-deoxy-2'-fluoro-5-methyl-4'-thioarabinouridine (4'S-FMAU) is described. Participation of the 3'-O-benzoyl protecting group in the thiosugar precursor influenced the stereochemistry of the N-glycosylation reaction in nonpolar solvents, permitting a higher beta/alpha ratio than previously observed for similar Lewis acid catalyzed glycosylations. Conformational analysis of the nucleoside using (3)J(HH) and (3)J(HF) NMR coupling constants together with the PSEUROT program showed that it adopted a predominantly northern conformation in contrast to 2'-deoxy-2'-fluoro-5-methylarabinouridine (FMAU), whose PSEUROT conformational analysis is presented here for the first time, which showed a dominantly southeast conformation. The sharp conformational switch attained by replacing the ring heteroatom is attributed to a decrease in relevant steric and stereoelectronic effects.
    DOI:
    10.1021/jo051844+
  • 作为产物:
    参考文献:
    名称:
    Synthesis and Conformational Analysis of 2‘-Fluoro-5-methyl-4‘-thioarabinouridine (4‘S-FMAU)
    摘要:
    An improved synthesis of 2'-deoxy-2'-fluoro-5-methyl-4'-thioarabinouridine (4'S-FMAU) is described. Participation of the 3'-O-benzoyl protecting group in the thiosugar precursor influenced the stereochemistry of the N-glycosylation reaction in nonpolar solvents, permitting a higher beta/alpha ratio than previously observed for similar Lewis acid catalyzed glycosylations. Conformational analysis of the nucleoside using (3)J(HH) and (3)J(HF) NMR coupling constants together with the PSEUROT program showed that it adopted a predominantly northern conformation in contrast to 2'-deoxy-2'-fluoro-5-methylarabinouridine (FMAU), whose PSEUROT conformational analysis is presented here for the first time, which showed a dominantly southeast conformation. The sharp conformational switch attained by replacing the ring heteroatom is attributed to a decrease in relevant steric and stereoelectronic effects.
    DOI:
    10.1021/jo051844+
点击查看最新优质反应信息

文献信息

  • SOLID FORM OF 4'-THIO-2'-FLUORONUCLEOSIDE PHOSPHAMIDE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF
    申请人:SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    公开号:US20190241603A1
    公开(公告)日:2019-08-08
    The present invention relates to a solid form of a compound of Formula (I), a method for preparing the solid form, a pharmaceutical composition comprising the solid form, and the use of the solid form in the treatment of a disease involving abnormal cell proliferation or a viral infectious disease.
    本发明涉及化合物Formula (I)的固体形式,制备该固体形式的方法,包含该固体形式的药物组合物,以及在治疗涉及异常细胞增殖或病毒感染疾病中使用该固体形式的用途。
  • [EN] PROCESS FOR PREPARING SUBSTITUTED 1-O-ACYL-2-DEOXY-2-FLUORO-4-THIO-ß-D-ARABINOFURANOSES<br/>[FR] PROCÉDÉ DE PRÉPARATION DE 1-O-ACYL-2-DÉSOXY-2-FLUORO-4-THIO-ß-D-ARABINOFURANOSES SUBSTITUÉS
    申请人:LIBRAMEDICINA INC
    公开号:WO2011074484A1
    公开(公告)日:2011-06-23
    The present invention relates to a process for preparing 1-O-acyl-2-deoxy-2-fluoro-4-thio-ƒタ-D-arabinofuranoses having formula I and intermediates thereof: wherein R1 represents -C(O)-C1-C6-alkyl or -C(O)-aryl; and R2 represents C1-C6-alkyl, C1-C4-perfluoroalkyl or aryl.
    本发明涉及一种制备具有I式和其中间体的1-O-酰基-2-去氧-2-氟-4-硫基-ƒタ-D-阿拉比呋喃糖的过程:其中R1代表-C(O)-C1-C6-烷基或-C(O)-芳基;R2代表C1-C6-烷基,C1-C4-全氟烷基或芳基。
  • PROCESS FOR PREPARING SUBSTITUTED 1-O-ACYL-2-DEOXY-2-FLUORO-4-THIO-BETA-D-ARABINOFURANOSES
    申请人:Voigtländer David
    公开号:US20110152542A1
    公开(公告)日:2011-06-23
    The present invention relates to a process for preparing 1-O-acyl-2-deoxy-2-fluoro-4-thio-β-D-arabinofuranoses having formula I and intermediates thereof: wherein R 1 represents —C(O)—C 1 -C 6 -alkyl or —C(O)-aryl; and R 2 represents C 1 -C 6 -alkyl, C 1 -C 4 -perfluoroalkyl or aryl.
    本发明涉及一种制备具有式I的1-O-酰基-2-去氧-2-氟-4-硫-β-D-阿拉比呋喃糖的方法和中间体:其中R1代表—C(O)—C1-C6-烷基或—C(O)-芳基;R2代表C1-C6-烷基,C1-C4-全氟烷基或芳基。
  • Process for preparing substituted 1-O-acyl-2-deoxy-2-fluoro-4-thio-ß-D-arabinofuranoses
    申请人:LibraMedicina, Inc.
    公开号:EP2388257A1
    公开(公告)日:2011-11-23
    The present invention relates to a process for preparing 1-0-acyl-2-deoxy-2-fluoro-4-thio-β-D-arabinofuranoses in which R1 represents C(O)-C1-C6-alkyl or C(O)-aryl; R2 represents C1-C6-alkyl, C1-C4-perfluoroalkyl or aryl, and also its intermediates as such.
    本发明涉及制备1-0-酰基-2-去氧-2-氟-4-硫-β-D-阿拉伯糖呋喃糖的方法,其中R1代表C(O)-C1-C6-烷基或C(O)-芳基;R2代表C1-C6-烷基,C1-C4-全氟烷基或芳基,以及其中间体。
  • Process for preparing substituted 1-O-acyl-2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranoses
    申请人:Libramedicina, Inc.
    公开号:EP2799432A1
    公开(公告)日:2014-11-05
    The present invention relates to a process for preparing 1-O-acyl-2-deoxy-2-ftuoro-4-thio-β-D-arabinofuranoses having formula I and intermediates thereof: wherein R1 represents -C(O)-C1-C6-alkyl or -C(O)-aryl; and R2 represents C1-C6-alkyl, C1-C4-perfluoroalkyl or aryl.
    本发明涉及一种制备具有式 I 的 1-O-acyl-2-deoxy-2-ftuoro-4-thio-β-D-arabinofuranoses 及其中间体的工艺: 其中R1代表-C(O)-C1-C6-烷基或-C(O)-芳基;R2代表C1-C6-烷基、C1-C4-全氟烷基或芳基。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐